Getting to lung rehab can be difficult for older adults with COPD, so Seattle startup Kivo Health brings the sessions into ...
Kivo Health, an AI-powered virtual care company transforming how seniors manage chronic disease, announced an oversubscribed $10 million Series A led by Allumia Ventures, with participation from ...
Kivo Health announced the Series A round this week, aiming to expand a program that pairs live, therapist-led video sessions ...
The Napanee Area Community Health Centre is inviting the public to its Chronic Obstructive Pulmonary Disease (COPD) Exercise Group.
They explained that COPD could not be diagnosed through the basic test alone, but that the reporter's lung function needed to ...
United Therapeutics, the Silver Spring, Maryland, and, North Carolina, developer of treprostinil-based therapies for lung ...
The new research, published in ERJ Open Research, found that nearly one in five asthma patients and one in three COPD ...
A systematic review of reviews finds that evidence on barriers and facilitators to digital medicine in chronic respiratory ...
PRA-216 is a novel IL-4Rα/TSLP bispecific antibody currently in Phase 2 development for asthma, COPD, and atopic dermatitis, with a Phase 2 study in EoE planned; patient data from all four trials ...
Napanee Area Community Health Centre invites the public to the COPD Exercise Group. The upcoming 14-week modified pulmonary rehab program is free to join and begins on Tuesday, Nov. 3. Classes will ...
Assuming a successful outcome in the SUMMIT study, United Therapeutics anticipates commencing a subsequent phase 3 registration study for treprostinil SMI in PH-COPD in 2028.
Bolt Biotherapeutics Inc. (Nasdaq: BOLT) has acquired clinical-stage biotechnology company Prana Therapies in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results